Thanks Pixie! Yes, the early version of Travelan Dr. Tacket studied in a human trial provided 100% protection against ETEC. 9 of the 10 patients given placebo and challenged with a liquid form of ETEC strain developed diarrhea, but 0 out of 10 patients given Dr. Tacket's early version of Travelan and similarly challenged with ETEC developed diarrhea. 0 out 10. 100% protection with P value of .0001. No side effects to drug were reported. An astounding and incredible result published in the New England Journal of Medicine.
The recent DoD Travelan/Shigella challenge on non-human primates (I don't think it would be ethical to do a Shigella/ETEC challenge on humans anymore ...at least....not in the developed world, anyway) provided equally compelling results. There is absolutely no doubt Travelan and IMM-124E work to prevent these terrible bacterial GI pathogenic diseases. The only question that remains is when Immuron can capitalize on it.
- Forums
- ASX - By Stock
- Carol Tacket, Travelan, and the New England Journal of Medicine
Thanks Pixie! Yes, the early version of Travelan Dr. Tacket...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMC (ASX) to my watchlist
|
|||||
Last
10.0¢ |
Change
-0.010(9.09%) |
Mkt cap ! $22.79M |
Open | High | Low | Value | Volume |
10.5¢ | 10.5¢ | 10.0¢ | $46.94K | 448.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 124450 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 74450 | 0.100 |
1 | 80000 | 0.098 |
2 | 62499 | 0.096 |
3 | 181877 | 0.095 |
1 | 32619 | 0.092 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 208068 | 1 |
0.115 | 119000 | 2 |
0.120 | 253253 | 5 |
0.125 | 100000 | 1 |
0.130 | 68000 | 4 |
Last trade - 15.58pm 02/08/2024 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |